Experimental or investigational: how to appeal
The insurer says the treatment is not yet proven for your condition and is therefore excluded. Peer-reviewed RCTs supporting the use.
Why this denial happens
- Newer drug, device, or procedure
- Off-label use
- Plan medical policy not updated to latest evidence
What overturns it
- Peer-reviewed RCTs supporting the use
- FDA approval or NCCN guideline citation
- Specialist letter explaining why standard therapy failed
- Independent medical review (external) if internal appeal denies
Evidence checklist
- ✓FDA label
- ✓NCCN, ASCO, or relevant specialty society guidelines
- ✓Two to three peer-reviewed studies
- ✓Specialist letter
External review reverses experimental denials at a high rate when the appeal includes peer-reviewed literature.
Draft an appeal for a "Experimental" denial
Free analysis identifies the cited policy and missing evidence. Then a finished letter.
FAQ
What does "Experimental or investigational" mean on a denial letter?+
The insurer says the treatment is not yet proven for your condition and is therefore excluded.
How long do I have to appeal?+
180 days from the date of denial for ERISA group plans and ACA marketplace plans. 60 days for Medicare Advantage. Check the denial letter for your specific deadline.
What is the success rate for this kind of appeal?+
Outcomes vary, but medical-necessity and step-therapy appeals overturn at meaningful rates when the appeal cites the insurer's own policy and the chart documents the required criteria.
Other denial reasons
Not legal or medical advice. This page is a self-help resource. You make your own decisions. Strip personal identifiers (name, date of birth, address, member ID) from any document before uploading or sharing. The information here summarizes commonly-published payer policies and federal rules; confirm against your specific plan document and the current denial letter before acting.